.jpg)
Tongsheng is committed to providing KSMs and intermediates for peptide drugs and chemical drugs. The products cover the screening of key materials for clinical new drugs,pilot trials and commercial production services. At present, it has enabled commercial projects such as hypoglycemic drugs, antiviral drugs, immunosuppressants and tumor drugs. After years of hard work, by establishing the most advanced R&D capabilities, Tongsheng has achieved significant success in providing customized synthesis services to the world's leading pharmaceutical companies, CDMO companies and API companies.
